Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are revolutionizing the management of metabolic and liver diseases, demonstrating effectiveness in controlling blood sugar levels and promoting liver repair
These agents include thiazolidinediones (PPAR- agonists), dipeptidyl peptidase-4 (DPP-4) inhibitors, sulfonylureas, sodium-glucose co-transporter 2 (SGLT2) inhibitors, -glucosidase inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists
When plants were subjected to Cd stress, we found that PAL-related genes in the phenylpropanoid biosynthesis pathway were upregulated, thus resulting in an increase in the levels of PAL
However, it was found effective in countering oxidative stress in a transgenic mouse model of amyloidosis when administered from four months of age [166]
Keeping up with routine wellness, including flu and COVID vaccinations, is also highly recommended while undergoing any significant medical treatment